Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GSK CEO Calls For Change In Business Model As World Power Moves To Emerging Economies

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - Fifty years from now, the period between 2005 and 2020 may be seen as critical years of change when the world witnessed a fundamental shift in economic power from a model dominated for the last 250 years to an evolutionary one led by emerging markets rather than Western economies

You may also be interested in...



GSK Senior VP Rogerio Ribeiro On Trends In Emerging Markets: An Interview With PharmAsia News

GSK operates in 172 emerging markets, which represented about 22% of the company’s revenues in 2013, and EM Head Rogerio Ribeiro is optimistic about further growth despite challenges in some markets.

GSK Shoots For Next Growth Phase In India With Bigger Push Into Vaccines, Pharma And Consumer Health

For the first time, the global board of directors of the British pharma and consumer healthcare giant met in India, and a series of moves to power further growth could be on the way.

GSK Shoots For Next Growth Phase In India With Bigger Push Into Vaccines, Pharma And Consumer Health

For the first time, the global board of directors of the British pharma and consumer healthcare giant met in India, and a series of moves to power further growth could be on the way.

Related Content

Latest News
UsernamePublicRestriction

Register

SC079118

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel